SIM
CODX

SummerHaven Investment Management’s Co-Diagnostics CODX Stock Holding History

SummerHaven Investment Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,827
Closed -$644K – 211
2022
Q2 		$644K Hold
3,827
– – 0.43% 127
2022
Q1 		$709K Buy
3,827
+176
+5% +$36.4K 0.4% 156
2021
Q4 		$978K Hold
3,651
– – 0.53% 71
2021
Q3 		$1.07M Buy
+3,651
New +$1.07M 0.62% 14

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SummerHaven Investment Management's CODX Position: Q3 2022 in Review

SummerHaven Investment Management sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 3,827 shares — an estimated $644K sold.

SummerHaven Investment Management first reported a position in CODX in Q3 2021 and held it in 4 quarters. The position peaked at $1.07M in Q3 2021. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • SummerHaven Investment Management reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • SummerHaven Investment Management sold 3,827 Co-Diagnostics shares in Q3 2022, an estimated $644K.
  • SummerHaven Investment Management first reported a position in Co-Diagnostics in Q3 2021 and held it in 4 quarters.
  • SummerHaven Investment Management's Co-Diagnostics position peaked at $1.07M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on SummerHaven Investment Management's 13F filing for Q3 2022, filed 20 Oct 2022.